XENE Competitors & Alternatives
Compare Xenon Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
XENE
Main Stock$54.79
Tradestie Score
66
Market Cap
$3.02B
Revenue Growth
-1.0%
Analyst Upside
+47.0%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.34
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$54.36
|
$6.02B | - | 58 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.42
|
$5.95B | - | 61 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$247.85
|
$5.92B | - | 58 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.40
|
$5.80B | 18.6 | 60 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$343.43
|
$5.20B | 46.4 | 58 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$52.11
|
$4.94B | - | 61 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$80.96
|
$4.93B | - | 55 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$82.00
|
$4.84B | - | 67 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More XENE Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry